Endocrinol Metab.  2010 Dec;25(4):326-339. 10.3803/EnM.2010.25.4.326.

Medical Service Utilization with Osteoporosis

• Jang S
• Park C
• Jang S
• Yoon HK
• Shin CS
• Kim DY
• Ha YC
• Lee SS
• Choi HJ
• Lee YK
• Kim BT
• Choi JY

• KMID: 1497759
• DOI: http://doi.org/10.3803/EnM.2010.25.4.326

Abstract

BACKGROUND
Although osteoporosis is increasing in the elderly population, attempts to analyze the patterns of medical service utilization for osteoporosis are currently not sufficient. The medical services and treatment patterns were investigated using Korea's National Health Insurance claims data, which includes all of the Korean population.
METHODS
Through the patient identification algorithm developed by using the administrative claims data in 2007, the adult patients (between 50-100 years) with osteoporosis were identified. The age and gender of the patients who used medical service for osteoporosis were described, in relation with six dichotomous variables. The medical service use patterns such as the type of medical institution and conducting bone mineral density measurement were investigated.
RESULTS
The number of patients who used medical service were 1,230,580 (females 89.9%). Sixty one point six percent of the patients were prescribed osteoporosis medicine (indicated for osteoporosis only), and 12.9% of the patients had experienced osteoporotic fracture. The primary medical institutions for treatment were clinics (54.3%), while hospitals were mainly used among the patients with a history of fracture and disease or drug use that may induce secondary osteoporosis. The number of visited medical institutions was 6.4 (as an outpatient) and 0.2 (as admissions) during 6 months. The proportion of patients who conducted bone mineral density measurements within one year before and after the diagnosis of osteoporosis was 66.7% and DXA was the most frequently used densitometry (46.3%). The average number of days for the prescriptions for osteoporosis medicine was 70 days.
CONCLUSION
In order to prevent further osteoporotic fractures, appropriate management and treatment should be implemented for osteoporosis patients. To do this, we need to understand the current state of medical service utilization and the treatment of osteoporosis using the National Health Insurance claims data.

Keyword

Osteoporosis; National Health Insurance Claims Data; Medical service utilization

MeSH Terms

Adult
Aged
Bone Density
Densitometry
Humans
National Health Programs
Osteoporosis
Osteoporotic Fractures
Prescriptions

Figure

• 

  Fig. 1 Patient identification algorithm using National Health Insurance claims data.

Reference

1. World Health Organization. WHO Technical Report Series, 843. 1994.

2. Korean National Health and Nutrition Examination Survey in 2008 results presentation. Korea Centers for Disease Control and Prevention;Available at: http://knhanes.cdc.go.kr.

3. Lim S, Koo BK, Lee EJ, Park JH, Kim MH, Shin KH, Ha YC, Cho NH, Shin CS. Incidence of hip fractures in Korea. J Bone Miner Metab. 2008. 26:400–405.

4. Shin CS, Jo NH, Kim Y, Kim SW, Park JH, Kim MH, Kim IK. Study of an osteoporosis management program in Korea. 2007. Seoul National University;Unpublished manuscript.

5. Rowe SM, Yoon TR, Ryang DH. An epidemiological study of hip fracture in Honam, Korea. Int Orthop. 1993. 17:139–143.

6. Kim NS. The effect of adherence to antidepressant treatment on relapse and recurrence of depression. 2008. Graduate school of Public Health, Seoul National University;Ph.D. Dissertation.

7. Kim JY, Kim HY, Im JH. Development of risk adjustment and prediction methods for care episodes using National Health Insurance Database. 2007. Seoul: Health Insurance Review & Assessment Service.

8. Westfall G, Littlefield R, Heaton A, Martin S. Methodology for identifying patients at high risk for osteoporotic fracture. Clin Ther. 2001. 23:1570–1588.

9. Ray WA, Griffin MR, Fought RL, Adams ML. Identification of fractures from computerized Medicare files. J Clin Epidemiol. 1992. 45:703–714.

10. Park BJ, Sung JH, Park KD, Seo SW, Kim SH. Improving the validity of health insurance disease code and the utilization of health insurance claim data. 2003. Seoul National University College of Medicine · Health Insurance Review & Assessment Service.

11. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005. 43:521–530.

12. The Korean Society of Bone Metabolism. Physician's Guide for Diagnosis & Treatment of Osteoporosis. 2008.

13. WHO Fracture Risk Assessment Tool (FRAX). Available at: http://www. shef.ac.uk/FRAX/index.jsp.

14. Clinician's guide to prevention and treatment of osteoporosis. 2008. USA: National osteoporosis foundation.

15. The Japanese Society for Bone and Mineral Research. 骨粗鬆症の予防と治療ガイドﾗイﾝ. 2006.

16. Kanis JA, Burlet N, Cooper C, Delmas PD, Reginster JY, Borgstrom F, Rizzoli R. European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2008. 19:399–428.

17. National Institute for Health and Clinical Excellence, Alendronate, etidronate, risedronate, raloxifene and strontium ranelate for the primary prevention of osteoporotic fragility fractures in postmenopausal women. 2008. 10.

18. Sambrook PN, Seeman E, Phillips SR, Ebeling PR. Osteoporosis Australia. National Prescribing Service: Preventing osteoporosis. outcomes of the Australian Fracture Prevention Summit. Med J Aust. 2002. 176:S1–S16.

19. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987. 40:373–383.

20. Kim KH. Review of comorbidities adjustment methodology using administrative claims data. HIRA Policy Trend. 2008. 2:58–62.

21. Sundararajan V, Quan H, Halfon P, Fushimi K, Luthi JC, Burnand B, Ghali WA. Cross-national comparative performance of three versions of the ICD-10 Charlson index. Med Care. 2007. 45:1210–1215.

22. Jang SM, Song HJ, Sheen SY, Sung YN, Kim SO, Kim CS. Development of assessment indicators of antihypertensive drugs. 2008. Health Insurance Review & Assessment Service.

23. Korean Diabetes Association. Health Insurance Review & Assessment Service, Diabetes in Korea. 2007.

24. Ministry for Health, Welfare and Family Affairs, Korean National Health and Nutrition Examination Survey in 2005. Korea Center for Disease Control & Prevention. Available at: http://knhanes.cdc.go.kr.

25. Kanis JA, Johnell O, Oden A, Borgstrom F, Johansson H, De Laet C, Jonsson B. Intervention thresholds for osteoporosis in men and women: a study based on data from Sweden. Osteoporos Int. 2005. 16:6–14.